Cargando…

Pleuro-Pulmonary Nocardiosis as Opportunistic Infection in a Patient with Chronic Hepatitis C under Combination Treatment with Pegylated Interferon, Ribavirin, and Boceprevir

Nocardiosis is an infrequent but serious pulmonary infection caused by Gram-positive aerobic actinomycetes. In this paper, we report on a 48-year-old patient with pleuropulmonary nocardiosis and cirrhosis due to chronic hepatitis C virus infection treated with triple antiviral treatment complicated...

Descripción completa

Detalles Bibliográficos
Autores principales:	Putz-Bankuti, Csilla, Kessler, Harald H., Valentin, Thomas, Leitner, Eva, Talakic, Emina, Schoellnast, Helmut, Fickert, Peter, Krejs, Guenter J., Stauber, Rudolf E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4208435/ https://www.ncbi.nlm.nih.gov/pubmed/25374720 http://dx.doi.org/10.1155/2013/529041

Ejemplares similares

CT perfusion imaging of the liver and the spleen in patients with cirrhosis: Is there a correlation between perfusion and portal venous hypertension?
por: Talakić, Emina, et al.
Publicado: (2017)

Clinical-Pathological Conference Series from the Medical University of Graz: Case No 161: A 42-year-old journalist with fatigue, elevated liver function tests, hyperglycemia and pruritus
por: Fabian, Elisabeth, et al.
Publicado: (2018)

Pulmonary Nocardiosis as an Opportunistic Infection in COVID-19
por: Laplace, Marc, et al.
Publicado: (2022)

Boceprevir
Publicado: (2012)

Boceprevir (BOC) and Telaprevir (TPV) therapeutic drug monitoring in HCV and HIV-HCV infected patients treated with triple therapy Ribavirine/Peg-interferon/Boceprevir or Telaprevir: impact of the antiretroviral (ARV) treatment
por: Chantry, AS, et al.
Publicado: (2014)

Peg-Interferon Plus Ribavirin with or without Boceprevir or Telaprevir for HCV Genotype 1: A Meta-Analysis on the Role of Response Predictors
por: Coppola, Nicola, et al.
Publicado: (2014)

Pegylated Interferon and Ribavirin Treatment for Hepatitis C Virus Infection
por: Kagawa, Tatehiro, et al.
Publicado: (2010)

Pegylated Interferon and Ribavirin in the Retreatment of Chronic Hepatitis C in Korea
por: Cho, Hyun Chin, et al.
Publicado: (2013)

Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin
por: Carvalho-Filho, Roberto J, et al.
Publicado: (2010)

Organizing Pneumonia Associated with Pegylated Interferon α and Ribavirin Therapy
por: Chopra, Amit, et al.
Publicado: (2015)

Clinical-Pathological Conference Series from the Medical University of Graz: Case No 159: 52-year-old patient with psoriasis and arthralgia of the finger joints
por: Fabian, Elisabeth, et al.
Publicado: (2016)

Consensus Interferon Plus Ribavirin for Hepatitis C Genotype 3 Patients Previously Treated With Pegylated Interferon Plus Ribavirin
por: Abbas, Zaigham, et al.
Publicado: (2013)

Pleuro-Pneumonia
Publicado: (1884)

Prediction of Treatment Week Eight Response & Sustained Virologic Response in Patients Treated with Boceprevir Plus Peginterferon Alfa and Ribavirin
por: Thompson, Alex, et al.
Publicado: (2014)

Pegylated Interferon and Ribavirin Dosing Strategies to Enhance Sustained Virologic Response
por: Chak, Eric, et al.
Publicado: (2010)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
por: Hartl, Janine, et al.
Publicado: (2012)

Thrombocytopenia in pegylated interferon and ribavirin combination therapy for chronic hepatitis C
por: Aizawa, Nobuhiro, et al.
Publicado: (2013)

Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?
por: Gonçales, Fernando L, et al.
Publicado: (2010)

Retreatment of Patients Nonresponsive to Pegylated Interferon and Ribavirin with Daily High-Dose Consensus Interferon
por: Meyer, Douglas F., et al.
Publicado: (2010)

Cutaneous side effects of combination therapy of pegylated interferon 2α and ribavirin
por: Raducan, Anca, et al.
Publicado: (2014)

Effects of Host and virus related factors on Interferon-α+ribavirin and Pegylated-interferon+ribavirin treatment outcomes in Chronic Hepatitis C patients
por: Akram, Madiha, et al.
Publicado: (2011)

Phylacogen in Pleuro-Pneumonia
por: DeSilva, George
Publicado: (1921)

Case of Pleuro-Pneumonia
por: Myrtle, A. S.
Publicado: (1868)

Case of Pleuro-Pneumonia
por: Cormack, John Rose
Publicado: (1880)

Case of Pleuro-Pneumonia
por: Cormack, John Rose
Publicado: (1880)

The Microbe of Pleuro-pneumonia
por: Nocard,, et al.
Publicado: (1898)

Contagious Pleuro-Pneumonia
Publicado: (1886)

Innoculation for Pleuro-Pueumonia
Publicado: (1883)

Sporadic Pleuro-pneumonia
por: Thomas, F. A.
Publicado: (1896)

Contagious Pleuro-pneumonia
Publicado: (1895)

Case of Pleuro-Tuberculosis
por: Norcom, F. B.
Publicado: (1856)

Boceprevir-induced Herpes Zoster
por: Babalı, Ayşegul, et al.
Publicado: (2018)

Increased Ribavirin Bioavailability Associated With Telaprevir Use in Hepatitis C Patients Treated With PEGylated -Interferon/Ribavirin/Telaprevir Triple Therapy
por: Pradat, Pierre, et al.
Publicado: (2015)

Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming
por: Zhang, Fangrong, et al.
Publicado: (2021)

Rapid Prediction of Treatment Futility of Boceprevir with Peginterferon-Ribavirin for Taiwanese Treatment Experienced Hepatitis C Virus Genotype 1-Infected Patients
por: Yang, Chi-Chieh, et al.
Publicado: (2015)

Subcutaneous Sarcoidosis during Pegylated Interferon Alfa and Ribavirin Treatment for Chronic Hepatitis C
por: Rodríguez-Lojo, R., et al.
Publicado: (2010)

Cryptococcal meningitis in a patient with chronic hepatitis C treated with pegylated-interferon and ribavirin
por: Lee, Tae-Hee, et al.
Publicado: (2014)

Efficacy and safety of pegylated interferon α and ribavirin in patients monoinfected with HCV genotype 4
por: Kozielewicz, Dorota, et al.
Publicado: (2018)

Telaprevir impairs renal function and increases blood ribavirin concentration during telaprevir/pegylated interferon/ribavirin therapy for chronic hepatitis C
por: Karino, Y, et al.
Publicado: (2014)

Effects of boceprevir and telaprevir on the pharmacokinetics of dolutegravir
por: Johnson, Mark, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_flbmlsnkrh4sltnill0114ul12